Don’t let the high cost of brand absence seizure therapy disrupt your treatment. We help eligible patients access Celontin (methsuximide) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
Celontin PAP for refractory absence seizure patients uninsured/underinsured.
Eligibility, neurology coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$580 | Save ~$510/mo |
| CVS Pharmacy | ~$600 | Save ~$530/mo |
| Walmart | ~$440 | Save ~$370/mo |
| Costco | ~$420 | Save ~$350/mo |
Specialty Pharmacy | ~$480 | Save ~$410/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
PAP free to apply, Celontin at no medication cost if approved. Our $69.95/month covers full advocacy.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Celontin:
Still $400–$600 per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Celontin assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Tivicay (dolutegravir, DTG) is a once-daily integrase strand transfer inhibitor (INSTI) used as a component of HIV-1 antiretroviral therapy. It must be combined with other antiretrovirals (NRTI backbone, or rilpivirine in the case of suppressed adults). Dolutegravir has a particularly high genetic barrier to resistance.
How Celontin Works:
Absence seizures arise from thalamocortical T-type calcium channel activity. Methsuximide and its active metabolite N-desmethylmethsuximide modulate T-type calcium channels and block neuronal firing, suppressing absence seizures.
Methsuximide is used when ethosuximide has failed — provides an alternative succinimide option. It also has some activity against complex partial seizures (less commonly used).
Form and use:
Celontin available as 150 mg and 300 mg capsules. Starting dose 300 mg/day; titrate weekly to response (usual maintenance 900–1200 mg/day in divided doses).
Generic availability:
There is no generic Celontin in the U.S. as of 2026. For most absence epilepsy patients, generic ethosuximide (Zarontin generic) is first-line — Celontin reserved for refractory cases. Generic valproate is another first-line option for absence epilepsy.
Warnings:
Celontin carries warnings similar to other succinimides: serious skin reactions (rare Stevens-Johnson syndrome), blood dyscrasias (agranulocytosis, aplastic anemia — periodic CBC), drug-induced SLE, psychiatric/behavioral changes, suicidal ideation (AED class effect), hepatotoxicity, and embryo-fetal toxicity.
$400–$600/month. No generic available. PAP at no cost; advocacy $69.95/month.
Celontin is for absence seizures REFRACTORY to ethosuximide or valproate. Most absence epilepsy patients respond to first-line ethosuximide (generic, cheap) or valproate (generic, cheap).
Both are succinimides for absence. Ethosuximide (Zarontin) is first-line, much better studied, available as generic. Methsuximide (Celontin) is reserved for refractory cases.
Yes — almost all absence epilepsy patients try ethosuximide or valproate first. Insurance plans typically require documentation of failed/intolerated first-line therapy before approving Celontin.
Similar to ethosuximide — GI symptoms (nausea, abdominal pain), CNS effects (drowsiness, ataxia), rare blood dyscrasias and skin reactions. Tell prescriber about new rash, fever, unusual fatigue, or unusual bruising/bleeding.
Limited safety data. Discuss with neurologist.
Generic ethosuximide and valproate are dramatically cheaper alternatives for most patients. Manufacturer copay or Epilepsy Foundation may help.
If struggling with Celontin cost, we can help — or explore first-line generic ethosuximide if you haven’t tried it. Check eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.